The APOBEC proteins constitute a family of cell-encoded polynucleotide 1 cytidine deaminases with diverse biological functions ranging from site-specific 2 mRNA editing and antibody diversification to the inhibition of retrovirus infection 3 and/or retrotransposition (5, 13, 15, 24). The execution of these activities is 4 frequently associated with RNA/DNA editing (also called hypermutation when 5 occurring at excessive levels) though deamination-independent effects have also 6 been described (3, 4, 6, 10, 16, 19-21, 23, 27, 34, 35, 39, 45, 46, 57, 67, 71).
1
cytidine deaminases with diverse biological functions ranging from site-specific 2 mRNA editing and antibody diversification to the inhibition of retrovirus infection 3 and/or retrotransposition (5, 13, 15, 24) . The execution of these activities is 4 frequently associated with RNA/DNA editing (also called hypermutation when 5 occurring at excessive levels) though deamination-independent effects have also 6 been described (3, 4, 6, 10, 16, 19-21, 23, 27, 34, 35, 39, 45, 46, 57, 67, 71) .
7
Because these protein mutagens are constitutively expressed under physiological 8 conditions, it stands to reason that their respective capacities to edit nucleic 9 acids must be regulated to avert deleterious mutations arising, as well as to 10 select intended substrates in the appropriate temporal and spatial manner.
11
Indeed, evidence is accumulating that APOBEC1, activation induced deaminase
12
(AID), A3G and A3F are subject to cellular regulatory mechanisms (5, 7, 8, 10, 13 15, 56, 59) . Notably, such mechanisms stand in contrast to the virus-driven 14 negative regulation of the antiviral proteins, A3G and A3F, that is mediated by 15 the Vif proteins of human and simian immunodeficiency viruses (HIVs and SIVs) 16 (4, 17, 32, 35, 36, 53, 65, 72) through the induction of proteasomal degradation 17 following recruitment of the cullin5-elonginB/C-Rbx ubiquitin ligase to A3F/G 18 (12, 33, 38, 40, 41, 54, 58, 68, 69) . (4, 28, 32, 53, 65, 72) .
7
Nevertheless, clear functional differences are evident: 1) the anti-HIV-1 potency 8 of A3F is significantly less than that of A3G (23, 70) ; 2) the levels of cytidine-to-9 uridine mutation detected in nascent HIV-1 cDNAs during virus infection in the 10 presence of A3F are lower than for A3G (4, 72); 3) the editing-independent anti-
11
HIV-1 effect of A3F may be more robust than that of A3G (23); 4) the preferred 12 dinucleotide substrate for A3F is TpC but CpC for A3G (edited cytidine 13 underlined) (4, 32, 65); and 5) there are differences in the specific residues in 14 HIV-1 Vif proteins that regulate A3F versus A3G (51, 55, 60) . Accordingly, we 15 wished to characterise A3F-containing RNPs and to identify similarities and 16 differences with A3G-RNPs that might explain these functional differences.
18
We used a previously described affinity purification strategy, whereby a 
5
immunoblotting of these samples with a Ro60-specific antibody confirmed the 6 absence of Ro60 from A3F-RNPs (data not shown).
8
Previous studies have demonstrated that the majority of the protein 9 interactions with A3G are sensitive to disruption by treatment with RNase,
10
indicating that RNA plays an important "bridging" or facilitating role in the
11
formation of the RNPs and that many RNP components are RNA binding proteins (11, 18, 31, 64) . We repeated this assessment here by treating NTAP-A3F/G-
12

13
containing lysates with 10 µg/ml RNaseA for 60 min prior to isolation of the 14 A3F/G complexes and SDS-PAGE (Fig. 1A, lanes 3 and 4) . As demonstrated 15 earlier (18), the majority of A3G-associated proteins were displaced by RNA Table 1 , many cellular RNA 7 binding proteins such as hnRNP proteins and ribosomal proteins as well as some 8 cytoskeletal and mitochondrial proteins were found. The majority of these 9 proteins have, in fact, been previously identified as constituents of A3G-RNPs in 10 three independent analyses (11, 18, 31) . Thus, this analysis confirms the very 11 similar compositions of A3F-and A3G-RNPs, but failed to find proteins that are 12 uniquely present in A3F-RNPs.
14
We next used co-tranfection of 293T cells and co-immunoprecipitation 15 with HA-epitope tagged A3F/G proteins to examine interactions with selected
16
RNA binding proteins (Fig. 1B) 
20
proteins were found in association with A3G but not with A3F. One curiosity of 21 these data is that A3F-HA migrates more rapidly in these gels than A3G-HA, yet (Fig. 1C) 
18
The recruitment of Alu RNA into cytoplasmic A3G-RNPs is thought to 
21
Since we found Alu RNA to be associated with cytoplasmic A3F-RNPs (Fig. 3A) ,
22
we asked whether A3F can also inhibit retrotransposition. To do this, we used (Fig. 3C ). As noted in some reports (9, 26, 30, 44, 57) , relatively modest 5 decreases in LINE-1 retrotranspostion of 60 to 70% could be seen for A3F and 6 A3G , whereas Alu retrotransposition was reduced substantially to ~5% by A3G
7
(11, 26). Likewise, we also found that A3F inhibited Alu transposition relatively 8 efficiently, to ~10% of the control. While the extent of suppression is greater 9 than that noted by others (26), we consider our findings to be consistent with 10 the presence of Alu RNA in A3F-RNPs (Fig. 3A) and with the many commonalities
11
we have described between A3F-and A3G-RNPs.
13
In sum, we have demonstrated that A3F, like A3G, is not only 14 incorporated into a complex set of RNPs in metabolically active cells (Fig. 1A) ,
15
but also localises to cytosolic sites of mRNA metabolism and storage (Fig. 2) .
16
The contents of these A3F/G-RNPs overlap extensively, with many of the 17 constituent proteins being the same RNA binding proteins (Fig. 1 ). These (Fig. 1A) . The absence of Ro60 and La from A3F-RNPs 2 was clear (Fig. 1) , and this correlated with the lack of Y RNAs in these 3 complexes (Fig. 3A) . Alu RNA was however present in A3F-RNPs (Fig. 3A) , and 4 robust inhibition of Alu retrotransposition was demonstrated (Fig. 3C) 
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